EY

EY (Ernst & Young) is a global professional services and consulting firm that provides critical market data and strategic analysis for the consumer products and beverage sectors.

In the context of the evolving alcohol market, EY has provided key data regarding the glp-1-impact-on-alcohol-consumption. Their research indicates that 44% of GLP-1 users drink less alcohol upon starting the medication. More significantly for long-term industry forecasting, EY data reports that 82% of users maintain these reduced drinking habits even after stopping the medication. This statistic is central to the industry’s understanding that the shift toward moderation and No/Low alcohol alternatives is a permanent structural change rather than a temporary pharmaceutical side effect.